New data on use of EndoZip™ to treat obese patients be presented at leading global medical conferences

Nitinotes, developer of EndoZip, a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on the EndoZip system will be presented at upcoming leading international medical conferences. These presentations will highlight findings from an ongoing clinical trial evaluating EndoZip as an innovative solution for minimally invasive obesity treatment.

"We are pleased to share the latest clinical progress of EndoZip with the global medical community at these prestigious events," said Lloyd Diamond, CEO of Nitinotes. "These presentations highlight our progress towards advancing obesity care with an automated solution that’s designed to be safe, effective, and accessible for both patients and clinicians. Physicians using EndoZip have noted its intuitive design and expressed enthusiasm about the potential to bring this unique solution into practice."

The presentations will also highlight the potential of the EndoZip system as an innovative approach for those with obesity-related comorbidities like hypertension and Type 2 diabetes mellitus (T2DM).

The presentations will be delivered by leading bariatric endoscopy experts Ivo Boskoski, M.D., PhD, Assistant Professor of Gastroenterology (RTDB), Università Cattolica del Sacro Cuore, and Maria Valeria Matteo, M.D., PhD, Gastroenterologist at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, at the following conferences:

  • ESGE Days 2025 | April 3-5 | Barcelona, Spain
    • April 4, 2:12 PM | Poster Dome 1 (P0)
    • Presenter: Dr. Maria Valeria Matteo
    • ID: MP140 - Moderated Poster Presentation
  • FISMAD 2025 | April 13-15 | Rome, Italy
    • April 15, 9:10–10:00 AM | Sala Nimes | Session OC.22 (Nutrition)
    • Presenter: Dr. Maria Valeria Matteo
    • ID: OC.22.2 - Oral Presentation
  • Digestive Disease Week (DDW) 2025 | May 3-6 | San Diego, USA
    • May 3, 10:22 AM | Location 5 (SDCC)
    • Presenter: Dr. Ivo Boskoski
    • ID: 4256645 - Oral Presentation
  • IFSO 2025 | May 14-17 | Venice, Italy
    • May 15, 5:45–5:54 PM | Sala Amici (Level 2)
    • Presenter: Dr. Maria Valeria Matteo
    • ID: 0820 (Abstract Session 03: Endoscopic Bariatric Procedures) - Oral Presentation

EndoZip is a fully automated endoscopic sleeve gastroplasty (ESG) suturing system designed to provide a minimally invasive treatment option for patients with obesity class I & II. The system aims to overcome key limitations of current bariatric treatments, including invasiveness and procedural complexity.

Nitinotes is actively progressing its regulatory efforts, with a CE mark application for EndoZip currently under review. The company is also engaging with the FDA to define the IDE pivotal study design that will support its regulatory submission upon completion.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hedonic eating fades with obesity—but neurotensin helps bring it back